Molnar FJ

References (3)

Title : Have last-observation-carried-forward analyses caused us to favour more toxic dementia therapies over less toxic alternatives? A systematic review - Molnar_2009_Open.Med_3_e31
Author(s) : Molnar FJ , Man-Son-Hing M , Hutton B , Fergusson DA
Ref : Open Med , 3 :e31 , 2009
Abstract :
PubMedSearch : Molnar_2009_Open.Med_3_e31
PubMedID: 19946392

Title : Systematic review of measures of clinical significance employed in randomized controlled trials of drugs for dementia - Molnar_2009_J.Am.Geriatr.Soc_57_536
Author(s) : Molnar FJ , Man-Son-Hing M , Fergusson D
Ref : J Am Geriatr Soc , 57 :536 , 2009
Abstract :
PubMedSearch : Molnar_2009_J.Am.Geriatr.Soc_57_536
PubMedID: 19187414

Title : Key methodological features of randomized controlled trials of Alzheimer's disease therapy. Minimal clinically important difference, sample size and trial duration - Burback_1999_Dement.Geriatr.Cogn.Disord_10_534
Author(s) : Burback D , Molnar FJ , St John P , Man-Son-Hing M
Ref : Dementia & Geriatric Cognitive Disorders , 10 :534 , 1999
Abstract :
PubMedSearch : Burback_1999_Dement.Geriatr.Cogn.Disord_10_534
PubMedID: 10559571